(Q46931179)
Statements
1 reference
Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT. (English)
1 reference
1 reference
Lawrence H Einhorn
1 reference
Mary J Brames
1 reference
Christopher L Corless
1 reference
Ali Madani
1 reference
1 February 2006
1 reference
29
1 reference
1
1 reference
12-13
1 reference
Identifiers
1 reference